| Year |
Citation |
Score |
| 2017 |
Fagan DH, Fettig LM, Avdulov S, Beckwith H, Peterson MS, Ho YY, Wang F, Polunovsky VA, Yee D. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation. Hormones & Cancer. PMID 28577281 DOI: 10.1007/S12672-017-0296-3 |
0.363 |
|
| 2015 |
Bitterman PB, Polunovsky VA. eIF4E-mediated translational control of cancer incidence. Biochimica Et Biophysica Acta. 1849: 774-80. PMID 25263391 DOI: 10.1016/J.Bbagrm.2014.09.007 |
0.549 |
|
| 2012 |
Issaenko OA, Bitterman PB, Polunovsky VA, Dahlberg PS. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype. Cancer Gene Therapy. 19: 609-18. PMID 22767218 DOI: 10.1038/Cgt.2012.39 |
0.431 |
|
| 2012 |
Jia Y, Polunovsky V, Bitterman PB, Wagner CR. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target. Medicinal Research Reviews. 32: 786-814. PMID 22495651 DOI: 10.1002/Med.21260 |
0.39 |
|
| 2012 |
Bitterman PB, Polunovsky VA. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle (Georgetown, Tex.). 11: 1097-107. PMID 22356766 DOI: 10.4161/Cc.11.6.19610 |
0.313 |
|
| 2012 |
McCauley JA, Evenson K, Truitt M, Kratzke R, Polunovsky V, Ruggero D, BItterman P, D'Cunha J. Abstract 2347: Translational control and lung cancer: eIF4F activation promotes tumorigenesis in vivo Cancer Research. 72: 2347-2347. DOI: 10.1158/1538-7445.Am2012-2347 |
0.409 |
|
| 2010 |
Jia Y, Chiu TL, Amin EA, Polunovsky V, Bitterman PB, Wagner CR. Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. European Journal of Medicinal Chemistry. 45: 1304-13. PMID 20060622 DOI: 10.1016/J.Ejmech.2009.11.054 |
0.346 |
|
| 2009 |
Ghosh B, Benyumov AO, Ghosh P, Jia Y, Avdulov S, Dahlberg PS, Peterson M, Smith K, Polunovsky VA, Bitterman PB, Wagner CR. Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. Acs Chemical Biology. 4: 367-77. PMID 19351181 DOI: 10.1021/Cb9000475 |
0.345 |
|
| 2008 |
Ghosh P, Cheng J, Chou TF, Jia Y, Avdulov S, Bitterman PB, Polunovsky VA, Wagner CR. Expression, purification and characterization of recombinant mouse translation initiation factor eIF4E as a dihydrofolate reductase (DHFR) fusion protein. Protein Expression and Purification. 60: 132-9. PMID 18479935 DOI: 10.1016/J.Pep.2008.03.024 |
0.311 |
|
| 2007 |
Larsson O, Li S, Issaenko OA, Avdulov S, Peterson M, Smith K, Bitterman PB, Polunovsky VA. Eukaryotic translation initiation factor 4E-induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors Cancer Research. 67: 6814-6824. PMID 17638893 DOI: 10.1158/0008-5472.Can-07-0752 |
0.464 |
|
| 2006 |
Polunovsky VA, Bitterman PB. The cap-dependent translation apparatus integrates and amplifies cancer pathways. Rna Biology. 3: 10-7. PMID 17114939 DOI: 10.4161/Rna.3.1.2718 |
0.324 |
|
| 2006 |
Larsson O, Perlman DM, Fan D, Reilly CS, Peterson M, Dahlgren C, Liang Z, Li S, Polunovsky VA, Wahlestedt C, Bitterman PB. Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Research. 34: 4375-86. PMID 16936314 DOI: 10.1093/Nar/Gkl558 |
0.361 |
|
| 2006 |
Jacobson BA, Alter MD, Kratzke MG, Frizelle SP, Zhang Y, Peterson MS, Avdulov S, Mohorn RP, Whitson BA, Bitterman PB, Polunovsky VA, Kratzke RA. Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Research. 66: 4256-62. PMID 16618749 DOI: 10.1158/0008-5472.Can-05-2879 |
0.384 |
|
| 2004 |
Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell. 5: 553-63. PMID 15193258 DOI: 10.1016/J.Ccr.2004.05.024 |
0.359 |
|
| 2004 |
Li S, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Polunovsky VA, Bitterman PB. Translation initiation factor 4E blocks endoplasmic reticulum-mediated apoptosis. The Journal of Biological Chemistry. 279: 21312-7. PMID 14990584 DOI: 10.1074/Jbc.M312467200 |
0.346 |
|
| 2002 |
Li S, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA, Bitterman PB. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Molecular and Cellular Biology. 22: 2853-61. PMID 11909977 DOI: 10.1128/Mcb.22.8.2853-2861.2002 |
0.348 |
|
| 1992 |
Chen B, Polunovsky V, White J, Blazar B, Nakhleh R, Jessurun J, Peterson M, Bitterman P. Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype. The Journal of Clinical Investigation. 90: 1778-85. PMID 1430204 DOI: 10.1172/Jci116052 |
0.362 |
|
| Show low-probability matches. |